With the Collaborative Cancer Cloud, Intel hopes to remove barriers that keep personalized medicine from scaling At 19, Eric Dishman began a fight with kidney cancer, and for 23 years he endured what he described as Russian roulette chemotherapy. It wasn’t until he had his DNA sequenced that doctors were able to administer a personalized treatment that placed Dishman’s cancer into remission. The p